数据链接：
官方服务：
资源简介：
COBRA vaccine tested in dried formulation with adjuvant
应用场景：
创建时间：
2025-10-30
相关数据集
Vaccine formulation for a single 2 mL dose.
“R” is denoted for rank of gene or protein. The vaccine for group A (placebo/control group) did not contain antigens. The vaccine for groups B, C and D contained antigens (R2, R5, R8, R18, R27, R37),
Figshare2016-08-09 更新50
Summary of the different experimental groups and candidate vaccine formulations.
All HA antigen treatments consisted of 5 µg of HA. 20% alum (aluminium hydroxide) was added as an adjuvant where indicated. *Lower case “c” refers to the control group for each designated HA treatment
NIAID Data Ecosystem20
Model validation (case 1).
Developing vaccines with a better stability is an area of improvement to meet the global health needs of preventing infectious diseases. With the advancement of data science and artificial intelligenc
NIAID Data Ecosystem20
Summary of the different experimental groups and candidate vaccine formulations.
All HA antigen treatments consisted of 5 µg of HA. 20% alum (aluminium hydroxide) was added as an adjuvant where indicated.*Lower case “c” refers to the control group for each designated HA treatment
Figshare2013-02-20 更新40
Recombinant antigen concentration used in each vaccine dose.
Recombinant antigen concentration used in each vaccine dose.
Figshare2017-08-25 更新20
